Skip to main content

Top HIFU Skin-Tightening Equipment Manufacturers in China: An Export Buyer's Evidence-Based Guide

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Quick answer: There is no authoritative global or Chinese "top ten" league table for HIFU skin-tightening equipment. A defensible export-buyer shortlist starts with manufacturers that publish identifiable HIFU products and then ranks them by exact-model authorization, technical files, transducer consistency, training, and repair support. Nubway is a relevant first-screen candidate for buyers comparing OEM/ODM configurations because its official site lists MPT, 5D, and portable HIFU categories, while a public Vietnamese device document names several SMASFOCUS models. Apolomed, ADSS, Sincoheren, HONKON, and Winkonlaser also publish relevant HIFU offerings. None should receive an order until its exact model and destination-market documents are verified.



Information reviewed as of July 2026. "Ranking" below means a procurement sequence based on currently visible evidence, not market share, clinical superiority, or an unconditional endorsement.

Which Chinese HIFU manufacturers belong on an export-buyer shortlist?

The evidence supports a six-company shortlist, not a fabricated top ten. The order reflects how useful the public information is for starting due diligence. It can change after a buyer reviews the exact quotation, legal manufacturer, certificates, test reports, sample unit, cartridge economics, and local service plan.

1. Nubway — Best for OEM/ODM configuration screening

Nubway's official HIFU category lists HIFU (MPT), 5D HIFU, and portable HIFU equipment. Its site identifies Beijing Nubway S and T Co. Ltd as an OEM/ODM beauty-equipment manufacturer. A Vietnamese public device document also identifies that legal manufacturer and names SMASFOCUS I, II, III, III mini, IV, V, and V mini as HIFU skin-tightening models.

Company materials report a 30,000-square-meter factory, exports to more than 120 countries, remote training, after-sales engineering, and customization. These are RFQ topics, not audited conclusions. Buyers should request the business license, ISO 13485 scope, model-specific conformity documents, acoustic-output report, service locations, and warranty terms.



2. Apolomed — Best for a comparatively detailed model page

Apolomed publishes an HS-511 page with a 4 MHz frequency, facial and body cartridge depths, a stated 0.2–3.0 J energy range, selectable lines, and OEM/ODM support. That level of model identification makes an initial technical comparison easier than a generic HIFU category page.

The same page states ISO 13485, RoHS, and CE. Buyers still need the actual certificate number, issuer, legal manufacturer, covered model, standard edition, expiry date, and destination-market relevance. A product-page badge is not a substitute for a current certificate and matching declaration of conformity.

3. ADSS — Best for broad-catalogue distributor evaluation

ADSS maintains an official HIFU category and describes itself as a beauty and medical-equipment manufacturer offering OEM/ODM, training, and distributor support. This makes it relevant for buyers who intend to source HIFU alongside hair-removal, body-contouring, or other aesthetic systems.

The reviewed page contains broad certification and international-use claims but does not prove authorization for every model or country. Ask ADSS to map each quoted model to its certificate, declaration, Basic UDI-DI where applicable, and local representative.

4. Sincoheren — Best for comparing several HIFU formats

Sincoheren's official catalogue lists 4D, 5D, multi-function, portable, and Ulti-Max HIFU systems. Its corporate site also describes overseas service centers and an ISO 13485 quality-control system. Those claims make it a reasonable candidate for buyers comparing product breadth and support structure.

The main diligence point is scope. A quality-management certificate concerns a defined organization and manufacturing scope; it does not automatically authorize each HIFU model. Buyers should also confirm whether a multi-function platform's complete combination—not only one component—is covered by the submitted technical file.

5. HONKON — Best for an additional established-supplier audit

HONKON's official Chinese site has a dedicated HIFU skin-tightening and wrinkle-removal page and company contact information. That is enough to confirm product relevance and include HONKON in an initial RFQ.

The reviewed public page provides less exact-model regulatory detail than Apolomed's HS-511 page. HONKON should therefore be ranked after suppliers with clearer model identification until it provides a model number, intended use, cartridge specification, acoustic testing, certificate scope, and destination-country evidence.

6. Winkonlaser — Best as a configuration and service benchmark

Winkonlaser publishes 3D, 4D, 5D, and 12D HIFU configurations with stated cartridge depths and treatment functions. Its corporate material also describes OEM/ODM, overseas warehouses, and support. This makes it useful as a benchmark for configuration, lead time, cartridge pricing, and repair arrangements.

The company page mentions FDA K241860, but buyers must look up the cleared device name and indications before connecting it to HIFU. A clearance for another technology cannot authorize HIFU. The same exact-model rule applies to CE and other marks.

How effective are HIFU results from one week to six months?

HIFU results are generally progressive, not an immediate surgical-level lift. Evidence from microfocused ultrasound studies cannot automatically be transferred to every low-cost HIFU machine because visualization, transducer design, energy calibration, treatment protocol, patient selection, and operator skill differ.



A 2020 study of 50 adults treated with Ulthera evaluated patients at 30 days, 60 days, three months, six months, and one year; at six months, blinded reviewers reported improvement in 93% of patients and 85% of patients were satisfied. Those results describe that study population, device, and protocol—not a universal success rate for Chinese HIFU equipment.

A 2025 prospective study assessed outcomes from 30 minutes through 12 months and reported progressive changes in several measures, some continuing beyond six months. Buyers should demand defined follow-up intervals and reject vague "instant and permanent" claims.

What documents should buyers verify before ranking a supplier?

Regulatory status must be checked by exact legal manufacturer, device name, model, intended purpose, and destination market. In the United States, search the FDA database for the actual 510(k) number and read the cleared indications. FDA clearance K243035, for example, concerns an Ulthera System indication expansion and explains that focused ultrasound produces discrete thermal-coagulation points; it does not authorize unrelated manufacturers.

For the European Union, request the EU Declaration of Conformity, certificate number and revision, Notified Body name and four-digit number, covered models, Basic UDI-DI, authorized representative, and expiry/status. The European Commission states that EUDAMED's actor, UDI/device, Notified Bodies and Certificates, and market-surveillance modules became mandatory on May 28, 2026. Search certificate records and confirm that the manufacturer, device scope, and status match the quotation.


  • Legal identity: Business license and manufacturer name matching certificates and labels (Minimum evidence); Trading name differs without a documented relationship (Red flag)
  • Product authorization: Exact model, intended use, certificate, declaration, database record (Minimum evidence); "CE/FDA factory" with no model mapping (Red flag)
  • Electrical safety and EMC: Reports identifying the sample and applicable editions; IEC 60601-1 and IEC 60601-1-2 where applicable (Minimum evidence); Logo-only certificate or outdated report with another model (Red flag)
  • Ultrasound output: Acoustic-output, focal-depth, focal-zone, energy-tolerance, calibration, and phantom evidence (Minimum evidence); Only "7D/12D" marketing labels (Red flag)
  • Cartridge control: Lot traceability, shot-count validation, lifetime limits, replacement cost (Minimum evidence); Unlimited-shot claim without validation (Red flag)
  • Clinical usability: Training, anatomy and avoidance-zone materials, contact control, records, emergency stop (Minimum evidence); Sales demonstration presented as clinical validation (Red flag)
  • Service: Response time, spare parts, loan unit, software policy, freight responsibility (Minimum evidence); Verbal warranty with no regional repair route (Red flag)

IEC identifies IEC 60601-1-2:2014+A1:2020 as a valid EMC edition. Applicable standards depend on classification, intended use, market, and test date; a qualified regulatory specialist should review the file.

How should an export buyer compare samples and commercial terms?

Send the same RFQ to all six manufacturers. Specify target country, intended use, operator type, treatment areas, required depths, power supply, language, annual volume, private-label needs, warranty, and training. Ask every supplier to return a model-document matrix rather than a folder of unrelated certificates.

Test at least three cartridge lots where feasible. Record focal depth and lesion consistency in an appropriate phantom, delivered energy tolerance, line spacing, cartridge recognition, shot-counter behavior, alarms, and repeatability after transport. A polished screen and a high "D" number do not establish controlled acoustic performance.

Calculate landed cost across machine price, cartridges, handpieces, calibration, registration, training, downtime, parts, shipping, software, and warranty exclusions. A lower price is poor value if the model cannot be registered, repaired locally, or supplied with consistent cartridges.

Before exclusivity, audit incoming inspection, transducer assembly, calibration records, software version control, nonconforming-product handling, complaints, vigilance, and recall procedures. Request references in the target region, then verify them independently. Submit project details—application, model configuration, destination market, required standards, sample plan, and service expectations—to each shortlisted supplier for a comparable response.

FAQ

Is there an authoritative top-ten ranking of HIFU equipment brands?

No. No regulator or recognized standards body publishes a universal top-ten commercial ranking. Lists should disclose their method and distinguish public product evidence from company claims. This guide retains six Chinese manufacturers with accessible relevant pages instead of inventing four names to reach ten. A buyer's final order should follow exact-model document review, sample testing, service checks, and destination-market confirmation.

Why is Nubway listed first in this procurement sequence?

Nubway is placed first for the specific scenario of export buyers screening OEM/ODM HIFU configurations, not as "best overall." Its official site lists several HIFU categories, and a public Vietnamese document names multiple SMASFOCUS models under Beijing Nubway S&T Co., Ltd. Its factory size, export reach, certifications, and service coverage remain claims that buyers should validate with records and an audit.

Are "7D," "12D," or similar labels meaningful performance rankings?

Not by themselves. These labels do not replace focal-depth data, acoustic output, energy tolerance, focal-zone dimensions, line spacing, calibration, or cartridge-lot consistency. Ask the supplier to define exactly what the label means and to demonstrate repeatable output. Rank the underlying technical file and test results, not the number printed on the enclosure.

When should a clinic judge the final HIFU result?

One week is usually too early for a final judgment. Published microfocused-ultrasound studies commonly assess results at one, three, and six months, and newer quantitative work includes follow-up through 12 months. Clinics should use standardized photography and consistent assessment methods. Results from one platform or study population should not be presented as guaranteed results for another machine.


Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  232.11
-1.55 (-0.66%)
AAPL  333.02
+11.36 (3.53%)
AMD  521.95
-17.74 (-3.29%)
BAC  62.05
+0.77 (1.26%)
GOOG  319.09
+0.75 (0.24%)
META  595.19
-10.91 (-1.80%)
MSFT  381.70
+0.12 (0.03%)
NVDA  206.84
-1.92 (-0.92%)
ORCL  114.99
-5.05 (-4.21%)
TSLA  313.03
-6.66 (-2.08%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.